Voyageur Pharmaceuticals Ltd (VM) — Cash Flow-to-Debt Ratio
Voyageur Pharmaceuticals Ltd (VM) has a Cash Flow-to-Debt Ratio of -0.20x as of November 2025, meaning its operating cash flow of CA$-369.98K could theoretically repay 0% of its total liabilities (CA$1.85 Million) in one year. See how much free cash does Voyageur Pharmaceuticals Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Voyageur Pharmaceuticals Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Voyageur Pharmaceuticals Ltd across 15 annual periods. Also explore Voyageur Pharmaceuticals Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Voyageur Pharmaceuticals Ltd (2011–2025)
Year-by-year debt coverage analysis for Voyageur Pharmaceuticals Ltd. For market capitalisation and broader financial context, see how much is Voyageur Pharmaceuticals Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.56x | CA$-2.89 Million | CA$1.85 Million | ▼ -1009.7% |
| 2024 | -0.14x | CA$-302.29K | CA$2.15 Million | ▲ +89.7% |
| 2023 | -1.36x | CA$-991.25K | CA$727.88K | ▲ +50.0% |
| 2022 | -2.72x | CA$-1.72 Million | CA$630.83K | ▼ -8.8% |
| 2021 | -2.50x | CA$-1.65 Million | CA$660.64K | ▼ -791.3% |
| 2020 | -0.28x | CA$-272.19K | CA$968.85K | ▲ +62.4% |
| 2019 | -0.75x | CA$-637.81K | CA$852.69K | ▼ -14.5% |
| 2018 | -0.65x | CA$-490.45K | CA$750.79K | ▼ -0.4% |
| 2017 | -0.65x | CA$-624.24K | CA$959.12K | ▲ +27.9% |
| 2016 | -0.90x | CA$-35.07K | CA$38.86K | ▲ +88.1% |
| 2015 | -7.61x | CA$-70.65K | CA$9.28K | ▼ -2424.0% |
| 2014 | -0.30x | CA$-23.66K | CA$78.45K | ▲ +95.3% |
| 2013 | -6.38x | CA$-54.73K | CA$8.58K | ▼ -6561.2% |
| 2012 | 0.10x | CA$2.32K | CA$23.47K | ▲ +107.4% |
| 2011 | -1.33x | CA$-28.19K | CA$21.21K | — |